| Year |
Citation |
Score |
| 2023 |
Toyonaga T, Khattar N, Wu Y, Lu Y, Naganawa M, Gallezot JD, Matuskey D, Mecca AP, Pittman B, Dias M, Nabulsi NB, Finnema SJ, Chen MK, Arnsten A, Radhakrishnan R, et al. The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [C]UCB-J. European Journal of Nuclear Medicine and Molecular Imaging. PMID 37955791 DOI: 10.1007/s00259-023-06487-8 |
0.365 |
|
| 2023 |
Schnakenberg Martin AM, Flynn LT, Sefik E, Luddy C, Cortes-Briones J, Skosnik PD, Pittman B, Ranganathan M, D'Souza DC. Preliminary study of the interactive effects of THC and ethanol on self-reported ability and simulated driving, subjective effects, and cardiovascular responses. Psychopharmacology. PMID 37045988 DOI: 10.1007/s00213-023-06356-0 |
0.635 |
|
| 2022 |
Radhakrishnan R, Guloksuz S, D'Souza DC, van Os J. Editorial: Gone to Pot: Examining the Association Between Cannabis Use and Medical/Psychiatric Disorders. Frontiers in Psychiatry. 13: 837757. PMID 35211046 DOI: 10.3389/fpsyt.2022.837757 |
0.39 |
|
| 2021 |
Radhakrishnan R, Skosnik PD, Ranganathan M, Naganawa M, Toyonaga T, Finnema S, Hillmer AT, Esterlis I, Huang Y, Nabulsi N, Carson RE, D'Souza DC. In vivo evidence of lower synaptic vesicle density in schizophrenia. Molecular Psychiatry. PMID 34135473 DOI: 10.1038/s41380-021-01184-0 |
0.408 |
|
| 2021 |
Radhakrishnan R, Ranganathan M, Skosnik PD, D'Souza DC. Exocannabinoids, Endocannabinoids, and Psychosis. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 6: 600-602. PMID 34099185 DOI: 10.1016/j.bpsc.2021.04.012 |
0.45 |
|
| 2021 |
Fang XT, Toyonaga T, Hillmer AT, Matuskey D, Holmes SE, Radhakrishnan R, Mecca AP, van Dyck CH, D'Souza DC, Esterlis I, Worhunsky PD, Carson RE. Identifying brain networks in synaptic density PET (C-UCB-J) with independent component analysis. Neuroimage. 118167. PMID 34000404 DOI: 10.1016/j.neuroimage.2021.118167 |
0.366 |
|
| 2021 |
Ranganathan M, Rahman M, Ganesh S, D'Souza DC, Skosnik PD, Radhakrishnan R, Pathania S, Mohanakumar T. Analysis of Circulating Exosomes Reveals a Peripheral Signature of Astrocytic Pathology in Schizophrenia. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-31. PMID 33821753 DOI: 10.1080/15622975.2021.1907720 |
0.45 |
|
| 2020 |
D'Souza DC, Radhakrishnan R, Naganawa M, Ganesh S, Nabulsi N, Najafzadeh S, Ropchan J, Ranganathan M, Cortes-Briones J, Huang Y, Carson RE, Skosnik P. Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder. Molecular Psychiatry. PMID 32973170 DOI: 10.1038/s41380-020-00891-4 |
0.437 |
|
| 2020 |
Ganesh S, Cortes-Briones J, Ranganathan M, Radhakrishnan R, Skosnik PD, D'Souza DC. Psychosis-relevant effects of intravenous delta-9-tetrahydrocannabinol - A mega analysis of individual participant-data from human laboratory studies. The International Journal of Neuropsychopharmacology. PMID 32385508 DOI: 10.1093/Ijnp/Pyaa031 |
0.451 |
|
| 2020 |
Hindley G, Beck K, Borgan F, Ginestet CE, McCutcheon R, Kleinloog D, Ganesh S, Radhakrishnan R, D'Souza DC, Howes OD. Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. The Lancet. Psychiatry. PMID 32197092 DOI: 10.1016/S2215-0366(20)30074-2 |
0.513 |
|
| 2019 |
Radhakrishnan R, Matuskey D, Nabulsi N, Gaiser E, Gallezot JD, Henry S, Planeta B, Lin SF, Ropchan J, Huang Y, Carson RE, D'Souza DC. In vivo 5-HT and 5-HT receptor availability in antipsychotic treated schizophrenia patients vs. unmedicated healthy humans measured with [C]GSK215083 PET. Psychiatry Research. Neuroimaging. 295: 111007. PMID 31760336 DOI: 10.1016/J.Pscychresns.2019.111007 |
0.477 |
|
| 2019 |
D'Souza DC, Ganesh S, Cortes-Briones J, Campbell MH, Emmanuel MK. Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure. Psychological Medicine. 1-8. PMID 31615592 DOI: 10.1017/S0033291719002721 |
0.325 |
|
| 2019 |
Roach BJ, D'Souza DC, Ford JM, Mathalon DH. Test-retest reliability of time-frequency measures of auditory steady-state responses in patients with schizophrenia and healthy controls. Neuroimage. Clinical. 23: 101878. PMID 31228795 DOI: 10.1016/J.Nicl.2019.101878 |
0.308 |
|
| 2019 |
Ranganathan M, De Aquino JP, Cortes-Briones JA, Radhakrishnan R, Pittman B, Bhakta S, D'Souza DC. Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans. Psychopharmacology. PMID 31187152 DOI: 10.1007/S00213-019-05273-5 |
0.389 |
|
| 2019 |
Radhakrishnan R, Ranganathan M, D'Souza DC. Medical Marijuana: What Physicians Need to Know. The Journal of Clinical Psychiatry. 80. PMID 31087827 DOI: 10.4088/Jcp.18Ac12537 |
0.33 |
|
| 2019 |
Orr C, Spechler P, Cao Z, Albaugh M, Chaarani B, Mackey S, D'Souza D, Allgaier N, Banaschewski T, Bokde ALW, Bromberg U, Büchel C, Burke Quinlan E, Conrod P, Desrivières S, et al. Grey Matter Volume Differences Associated with Extremely Low Levels of Cannabis Use in Adolescence. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30643026 DOI: 10.1523/Jneurosci.3375-17.2018 |
0.442 |
|
| 2018 |
D'Souza DC, Cortes-Briones J, Creatura G, Bluez G, Thurnauer H, Deaso E, Bielen K, Surti T, Radhakrishnan R, Gupta A, Gupta S, Cahill J, Sherif MA, Makriyannis A, Morgan PT, et al. Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial. The Lancet. Psychiatry. PMID 30528676 DOI: 10.1016/S2215-0366(18)30427-9 |
0.487 |
|
| 2018 |
Breier A, Buchanan RW, D'Souza D, Nuechterlein K, Marder S, Dunn W, Preskorn S, Macaluso M, Wurfel B, Maguire G, Kakar R, Highum D, Hoffmeyer D, Coskinas E, Litman R, et al. Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study. Schizophrenia Research. PMID 30478008 DOI: 10.1016/J.Schres.2018.11.002 |
0.345 |
|
| 2018 |
Boggs DL, Cortes-Briones JA, Surti T, Luddy C, Ranganathan M, Cahill JD, Sewell AR, D'Souza DC, Skosnik PD. The dose-dependent psychomotor effects of intravenous delta-9-tetrahydrocannabinol (Δ-THC) in humans. Journal of Psychopharmacology (Oxford, England). 269881118799953. PMID 30255720 DOI: 10.1177/0269881118799953 |
0.344 |
|
| 2018 |
De Aquino JP, Sherif M, Radhakrishnan R, Cahill JD, Ranganathan M, D'Souza DC. The Psychiatric Consequences of Cannabinoids. Clinical Therapeutics. PMID 29678279 DOI: 10.1016/J.Clinthera.2018.03.013 |
0.473 |
|
| 2018 |
Radhakrishnan R, Nabulsi N, Gaiser E, Gallezot JD, Henry S, Planeta B, Lin SF, Ropchan J, Williams W, Morris E, D'Souza DC, Huang Y, Carson RE, Matuskey D. Age-related change in 5-HT6 receptor availability in healthy male volunteers measured withC-GSK215083 PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29626125 DOI: 10.2967/Jnumed.117.206516 |
0.388 |
|
| 2018 |
Skosnik PD, Hajós M, Cortes-Briones JA, Edwards CR, Pittman BP, Hoffmann WE, Sewell AR, D'Souza DC, Ranganathan M. Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans. Neuropharmacology. PMID 29604295 DOI: 10.1016/J.Neuropharm.2018.03.036 |
0.305 |
|
| 2017 |
Hamilton HK, D'Souza DC, Ford JM, Roach BJ, Kort NS, Ahn KH, Bhakta S, Ranganathan M, Mathalon DH. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia. Schizophrenia Research. PMID 28711472 DOI: 10.1016/J.Schres.2017.06.040 |
0.396 |
|
| 2017 |
Ranganathan M, Radhakrishnan R, Addy PH, Schnakenberg A, Williams A, Carbuto M, Elander J, Pittman B, Andrew Sewell R, Skosnik PD, D'Souza DC. Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 28642081 DOI: 10.1016/J.Pnpbp.2017.06.019 |
0.51 |
|
| 2017 |
Boggs DL, Surti TS, Esterlis I, Pittman B, Cosgrove K, Sewell RA, Ranganathan M, D'Souza DC. Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia. Schizophrenia Research. PMID 28392208 DOI: 10.1016/J.Schres.2017.03.047 |
0.337 |
|
| 2016 |
Wilkinson ST, Radhakrishnan R, D'Souza DC. A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications. The Journal of Clinical Psychiatry. 77: 1050-64. PMID 27561138 DOI: 10.4088/Jcp.15R10036 |
0.386 |
|
| 2016 |
Sherif M, Radhakrishnan R, D'Souza DC, Ranganathan M. Human Laboratory Studies on Cannabinoids and Psychosis. Biological Psychiatry. 79: 526-38. PMID 26970363 DOI: 10.1016/J.Biopsych.2016.01.011 |
0.537 |
|
| 2015 |
Wilkinson ST, Yarnell S, Radhakrishnan R, Ball SA, D'Souza DC. Marijuana Legalization: Impact on Physicians and Public Health. Annual Review of Medicine. PMID 26515984 DOI: 10.1146/Annurev-Med-050214-013454 |
0.466 |
|
| 2015 |
Ranganathan M, Cortes-Briones J, Radhakrishnan R, Thurnauer H, Planeta B, Skosnik P, Gao H, Labaree D, Neumeister A, Pittman B, Surti T, Huang Y, Carson RE, D'Souza DC. Reduced Brain Cannabinoid Receptor Availability In Schizophrenia. Biological Psychiatry. PMID 26432420 DOI: 10.1016/J.Biopsych.2015.08.021 |
0.467 |
|
| 2015 |
D'Souza DC, Ranganathan M. Medical Marijuana: Is the Cart Before the Horse? Jama. 313: 2431-2. PMID 26103026 DOI: 10.1001/Jama.2015.6407 |
0.345 |
|
| 2015 |
Ahn KH, Sewell A, Elander J, Pittman B, Ranganathan M, Gunduz-Bruce H, Krystal J, D'Souza DC. Role of GABA Deficit in Sensitivity to the Psychotomimetic Effects of Amphetamine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 25953357 DOI: 10.1038/Npp.2015.132 |
0.404 |
|
| 2015 |
Radhakrishnan R, Skosnik PD, Cortes-Briones J, Sewell RA, Carbuto M, Schnakenberg A, Cahill J, Bois F, Gunduz-Bruce H, Pittman B, Ranganathan M, D'Souza DC. GABA Deficits Enhance the Psychotomimetic Effects of Δ(9)-THC. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 2047-56. PMID 25728472 DOI: 10.1038/Npp.2015.58 |
0.739 |
|
| 2015 |
Cortes-Briones J, Skosnik PD, Mathalon D, Cahill J, Pittman B, Williams A, Sewell RA, Ranganathan M, Roach B, Ford J, D'Souza DC. Δ(9)-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 2124-34. PMID 25709097 DOI: 10.1038/Npp.2015.53 |
0.356 |
|
| 2014 |
Wilkinson ST, Radhakrishnan R, D'Souza DC. Impact of Cannabis Use on the Development of Psychotic Disorders. Current Addiction Reports. 1: 115-128. PMID 25767748 DOI: 10.1007/S40429-014-0018-7 |
0.485 |
|
| 2014 |
Radhakrishnan R, Wilkinson ST, D'Souza DC. Gone to Pot - A Review of the Association between Cannabis and Psychosis. Frontiers in Psychiatry. 5: 54. PMID 24904437 DOI: 10.3389/Fpsyt.2014.00054 |
0.5 |
|
| 2014 |
Ranganathan M, Sewell RA, Carbuto M, Elander J, Schnakenberg A, Radhakrishnan R, Pittman B, D'Souza DC. Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism. Psychopharmacology. 231: 2385-93. PMID 24424782 DOI: 10.1007/S00213-013-3402-4 |
0.721 |
|
| 2014 |
D'Souza DC, Ranganathan M, Addy P, Thurnauer H, Schnakenberg A, Pittman B, Radhakrishnan R, Skosnik P, Andrew Sewell R. Poster #T56 LEARN BEFORE YOU BURN: THC IMPAIRS ENCODING BUT NOT RETRIEVAL OF VERBAL INFORMATION Schizophrenia Research. 153: S308-S309. DOI: 10.1016/S0920-9964(14)70873-4 |
0.711 |
|
| 2014 |
D'Souza DC, Cortes J, Ranganathan M, Thurnauer H, Planeta B, Radhakrishnan R, Huang Y, Carson R, Skosnik P. Poster #S268 DECREASED BRAIN CANNABINOID RECEPTOR (CB1R) AVAILABILITY IN CANNABIS DEPENDENCE RAPIDLY NORMALIZES WITH ABSTINENCE Schizophrenia Research. 153: S187. DOI: 10.1016/S0920-9964(14)70547-X |
0.476 |
|
| 2014 |
D'Souza DC, Thurnauer H, Ranganathan M, Cortes J, Radhakrishnan R, Carson R, Huang YH, Planeta-Wilson B. 5:30 PM IN VIVO EVIDENCE OF REDUCED BRAIN CANNABINOID RECEPTORS IN SCHIZOPHRENIA Schizophrenia Research. 153: S52. DOI: 10.1016/S0920-9964(14)70171-9 |
0.518 |
|
| 2013 |
Boggs DL, Ranganathan M, Sewell RA, Madonick S, D'Souza DC. Pilot study of intravenous nicotine effects on cognitive performance in schizophrenia. Schizophrenia Research. 150: 323-4. PMID 23953216 DOI: 10.1016/J.Schres.2013.07.045 |
0.354 |
|
| 2013 |
Driesen NR, McCarthy G, Bhagwagar Z, Bloch MH, Calhoun VD, D'Souza DC, Gueorguieva R, He G, Leung HC, Ramani R, Anticevic A, Suckow RF, Morgan PT, Krystal JH. The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2613-22. PMID 23856634 DOI: 10.1038/Npp.2013.170 |
0.309 |
|
| 2013 |
Gunduz-Bruce H, Oliver S, Gueorguieva R, Forselius-Bielen K, D'Souza DC, Zimolo Z, Tek C, Kaliora S, Ray S, Petrides G. Efficacy of pimozide augmentation for clozapine partial responders with schizophrenia. Schizophrenia Research. 143: 344-7. PMID 23219861 DOI: 10.1016/J.Schres.2012.11.008 |
0.355 |
|
| 2013 |
Sewell RA, Schnakenberg A, Elander J, Radhakrishnan R, Williams A, Skosnik PD, Pittman B, Ranganathan M, D'Souza DC. Acute effects of THC on time perception in frequent and infrequent cannabis users. Psychopharmacology. 226: 401-13. PMID 23179965 DOI: 10.1007/S00213-012-2915-6 |
0.748 |
|
| 2013 |
D'Souza DC, Radhakrishnan R, Perry E, Bhakta S, Singh NM, Yadav R, Abi-Saab D, Pittman B, Chaturvedi SK, Sharma MP, Bell M, Andrade C. Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 492-503. PMID 23093223 DOI: 10.1038/Npp.2012.208 |
0.524 |
|
| 2013 |
Woods SW, Walsh BC, Hawkins KA, Miller TJ, Saksa JR, D'Souza DC, Pearlson GD, Javitt DC, McGlashan TH, Krystal JH. Glycine treatment of the risk syndrome for psychosis: report of two pilot studies. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 931-40. PMID 23089076 DOI: 10.1016/J.Euroneuro.2012.09.008 |
0.347 |
|
| 2013 |
Radhakrishnan R, Addy PH, Sewell RA, Skosnik PD, Ranganathan M, D'Souza DC. Cannabis, Cannabinoids, and the Association with Psychosis The Effects of Drug Abuse On the Human Nervous System. 423-474. DOI: 10.1016/B978-0-12-418679-8.00014-9 |
0.412 |
|
| 2012 |
Ranganathan M, Schnakenberg A, Skosnik PD, Cohen BM, Pittman B, Sewell RA, D'Souza DC. Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans. Biological Psychiatry. 72: 871-9. PMID 22817868 DOI: 10.1016/J.Biopsych.2012.06.012 |
0.77 |
|
| 2012 |
D'Souza DC, Ahn K, Bhakta S, Elander J, Singh N, Nadim H, Jatlow P, Suckow RF, Pittman B, Ranganathan M. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia. Biological Psychiatry. 72: 785-94. PMID 22717030 DOI: 10.1016/J.Biopsych.2012.05.009 |
0.387 |
|
| 2012 |
Skosnik PD, D'Souza DC, Steinmetz AB, Edwards CR, Vollmer JM, Hetrick WP, O'Donnell BF. The effect of chronic cannabinoids on broadband EEG neural oscillations in humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2184-93. PMID 22713908 DOI: 10.1038/Npp.2012.65 |
0.322 |
|
| 2012 |
Keefe RS, Vinogradov S, Medalia A, Buckley PF, Caroff SN, D'Souza DC, Harvey PD, Graham KA, Hamer RM, Marder SM, Miller DD, Olson SJ, Patel JK, Velligan D, Walker TM, et al. Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial. The Journal of Clinical Psychiatry. 73: 1016-22. PMID 22687548 DOI: 10.4088/Jcp.11M07100 |
0.32 |
|
| 2012 |
Skosnik PD, Ranganathan M, D'Souza DC. Cannabinoids, working memory, and schizophrenia. Biological Psychiatry. 71: 662-3. PMID 22449262 DOI: 10.1016/J.Biopsych.2012.02.028 |
0.359 |
|
| 2012 |
D'Souza DC, Fridberg DJ, Skosnik PD, Williams A, Roach B, Singh N, Carbuto M, Elander J, Schnakenberg A, Pittman B, Sewell RA, Ranganathan M, Mathalon D. Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δâ¹-THC in humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1632-46. PMID 22334121 DOI: 10.1038/Npp.2012.8 |
0.765 |
|
| 2012 |
Ranganathan M, Carbuto M, Braley G, Elander J, Perry E, Pittman B, Radhakrishnan R, Sewell RA, D'Souza DC. Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 1251-64. PMID 22243563 DOI: 10.1017/S1461145711001830 |
0.563 |
|
| 2012 |
D'Souza DC, Esterlis I, Carbuto M, Krasenics M, Seibyl J, Bois F, Pittman B, Ranganathan M, Cosgrove K, Staley J. Lower ß2*-nicotinic acetylcholine receptor availability in smokers with schizophrenia. The American Journal of Psychiatry. 169: 326-34. PMID 22193533 DOI: 10.1176/Appi.Ajp.2011.11020189 |
0.325 |
|
| 2012 |
D'Souza DC, Singh N, Elander J, Carbuto M, Pittman B, Udo de Haes J, Sjogren M, Peeters P, Ranganathan M, Schipper J. Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1036-46. PMID 22113087 DOI: 10.1038/Npp.2011.295 |
0.428 |
|
| 2012 |
Gunduz-Bruce H, Reinhart RM, Roach BJ, Gueorguieva R, Oliver S, D'Souza DC, Ford JM, Krystal JH, Mathalon DH. Glutamatergic modulation of auditory information processing in the human brain. Biological Psychiatry. 71: 969-77. PMID 22036036 DOI: 10.1016/J.Biopsych.2011.09.031 |
0.384 |
|
| 2012 |
Carbuto M, Sewell RA, Williams A, Forselius-Bielen K, Braley G, Elander J, Pittman B, Schnakenberg A, Bhakta S, Perry E, Ranganathan M, D'Souza DC. The safety of studies with intravenous Δâ¹-tetrahydrocannabinol in humans, with case histories. Psychopharmacology. 219: 885-96. PMID 21845389 DOI: 10.1007/S00213-011-2417-Y |
0.767 |
|
| 2011 |
Krystal JH, Petrakis IL, Limoncelli D, Nappi SK, Trevisan L, Pittman B, D'Souza DC, Suckow RF. Characterization of the interactive effects of glycine and D-cycloserine in men: further evidence for enhanced NMDA receptor function associated with human alcohol dependence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 701-10. PMID 21124304 DOI: 10.1038/Npp.2010.203 |
0.327 |
|
| 2011 |
Ahn K, Gil R, Seibyl J, Sewell RA, D'Souza DC. Probing GABA receptor function in schizophrenia with iomazenil. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 677-83. PMID 21068719 DOI: 10.1038/Npp.2010.198 |
0.389 |
|
| 2010 |
Sewell RA, Skosnik PD, Garcia-Sosa I, Ranganathan M, D'Souza DC. [Behavioral, cognitive and psychophysiological effects of cannabinoids: relevance to psychosis and schizophrenia]. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 32: S15-30. PMID 20512267 DOI: 10.1590/S1516-44462010000500005 |
0.386 |
|
| 2010 |
Corlett PR, D'Souza DC, Krystal JH. Capgras syndrome induced by ketamine in a healthy subject. Biological Psychiatry. 68: e1-2. PMID 20385373 DOI: 10.1016/J.Biopsych.2010.02.015 |
0.322 |
|
| 2010 |
Keefe R, Vinogradov S, Medalia A, Buckley P, Caroff S, D'Souza D, Harvey P, Graham K, Marder S, Miller D, Olson S, Patel J, Velligan D, Walker T, Haim A, et al. Feasibility Study Of Multi-Site Cognitive Remediation In The Schizophrenia Trials Network (Crstn) Schizophrenia Research. 117: 394-394. DOI: 10.1016/J.Schres.2010.02.712 |
0.321 |
|
| 2009 |
Sewell RA, Ranganathan M, D'Souza DC. Cannabinoids and psychosis. International Review of Psychiatry (Abingdon, England). 21: 152-62. PMID 19367509 DOI: 10.1080/09540260902782802 |
0.391 |
|
| 2008 |
D'Souza DC, Braley G, Blaise R, Vendetti M, Oliver S, Pittman B, Ranganathan M, Bhakta S, Zimolo Z, Cooper T, Perry E. Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans. Psychopharmacology. 198: 587-603. PMID 18228005 DOI: 10.1007/s00213-007-1042-2 |
0.302 |
|
| 2008 |
D'Souza DC, Ranganathan M, Braley G, Gueorguieva R, Zimolo Z, Cooper T, Perry E, Krystal J. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2505-16. PMID 18185500 DOI: 10.1038/Sj.Npp.1301643 |
0.394 |
|
| 2008 |
D'Souza DC, Mathalon D, Perry E. LABORATORY STUDIES OF DELTA-9-THC IN HUMANS: RELEVANCE TO SCHIZOPHRENIA Schizophrenia Research. 102: 1. DOI: 10.1016/S0920-9964(08)70003-3 |
0.356 |
|
| 2007 |
D'Souza DC. Cannabinoids and psychosis. International Review of Neurobiology. 78: 289-326. PMID 17349865 DOI: 10.1016/S0074-7742(06)78010-2 |
0.404 |
|
| 2006 |
D'Souza DC, Gil RB, Madonick S, Perry EB, Forselius-Bielen K, Braley G, Donahue L, Tellioglu T, Zimolo Z, Gueorguieva R, Krystal JH. Enhanced sensitivity to the euphoric effects of alcohol in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2767-75. PMID 16985503 DOI: 10.1038/Sj.Npp.1301207 |
0.369 |
|
| 2006 |
Krystal JH, Madonick S, Perry E, Gueorguieva R, Brush L, Wray Y, Belger A, D'Souza DC. Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1793-800. PMID 16395307 DOI: 10.1038/Sj.Npp.1300994 |
0.398 |
|
| 2005 |
D'Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G, Gueorguieva R, Cooper TB, Krystal JH. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biological Psychiatry. 57: 594-608. PMID 15780846 DOI: 10.1016/J.Biopsych.2004.12.006 |
0.316 |
|
| 2005 |
Cho HS, D'Souza DC, Gueorguieva R, Perry EB, Madonick S, Karper LP, Abi-Dargham A, Belger A, Abi-Saab W, Lipschitz D, Bennet A, Seibyl JP, Krystal JH. Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine. Psychopharmacology. 179: 136-43. PMID 15682309 DOI: 10.1007/S00213-004-2066-5 |
0.341 |
|
| 2004 |
D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1558-72. PMID 15173844 DOI: 10.1038/Sj.Npp.1300496 |
0.424 |
|
| 2003 |
Jacobsen L, Mencl W, D'Souza D, Pugh K, Skudlarski P, Abi-Saab W, Krystal J. Impact of nicotine on brain function in smokers with schizophrenia Schizophrenia Research. 60: 223-224. DOI: 10.1016/S0920-9964(03)81196-9 |
0.318 |
|
| 2003 |
D'Souza D, Perry E, Riccardi P, Abi-Saab W, Krystal J. Cannabinoids and psychosis: Pharmacological studies with IV delta-9-THC in humans Schizophrenia Research. 60: 310. DOI: 10.1016/S0920-9964(03)80247-5 |
0.32 |
|
| 2001 |
Warner MD, Walker AM, D'Souza DC, Lee D, Nasseri D, Peabody CA. Lower prolactin bioactivity in unmedicated schizophrenic patients. Psychiatry Research. 102: 249-54. PMID 11440775 DOI: 10.1016/S0165-1781(01)00256-6 |
0.323 |
|
| 1999 |
Krystal JH, D'Souza DC, Karper LP, Bennett A, Abi-Dargham A, Abi-Saab D, Cassello K, Bowers MB, Vegso S, Heninger GR, Charney DS. Interactive effects of subanesthetic ketamine and haloperidol in healthy humans. Psychopharmacology. 145: 193-204. PMID 10463321 DOI: 10.1007/S002130051049 |
0.308 |
|
| 1998 |
Abi-Saab WM, D'Souza DC, Moghaddam B, Krystal JH. The NMDA antagonist model for schizophrenia: promise and pitfalls. Pharmacopsychiatry. 31: 104-9. PMID 9754841 DOI: 10.1055/S-2007-979354 |
0.387 |
|
| 1998 |
Krystal JH, Karper LP, Bennett A, D'Souza DC, Abi-Dargham A, Morrissey K, Abi-Saab D, Bremner JD, Bowers MB, Suckow RF, Stetson P, Heninger GR, Charney DS. Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans. Psychopharmacology. 135: 213-29. PMID 9498724 DOI: 10.1007/s002130050503 |
0.309 |
|
| 1998 |
D'Souza D, Belger A, Abi-Saab W, Adams S, Gil R, Larvey K, Cassello K, Sernyak M, Krystal J. 435. Dose-response of THC effects in schizophrenics and healthy controls Biological Psychiatry. 43: S130-S131. DOI: 10.1016/S0006-3223(98)90883-6 |
0.322 |
|
| 1995 |
D'Souza D, Morrissey K, Abi-Saab D, Damon D, Gil R, Bennett A, Krystal J. Intravenous glycine and oral d-Cycloserine effects on CSF Amino acids, plasma hormones and behavior in healthy humans: Implications for schizophrenia Schizophrenia Research. 15: 147. DOI: 10.1016/0920-9964(95)95456-J |
0.325 |
|
| 1995 |
Abi-Dargham A, Krystal J, Laruelle M, D'Souza D, Zoghbi S, Brenner L, Gil R, Sernyak M, Baldwin R, Zubal G, Hoffer P, Charney D, Innis R. Spect imaging of the benzodiazepine receptor in schizophrenics and healthy subjects Schizophrenia Research. 15: 75. DOI: 10.1016/0920-9964(95)95236-3 |
0.303 |
|
| 1994 |
D'Souza D, Gil R, Abi-Dargham A, Karper L, Abi-Saab D, Morrissey K, Brenner L, Charney D, Krystal J. Tryptophan depletion paradigm: Implications for schizophrenia Biological Psychiatry. 35: 703. DOI: 10.1016/0006-3223(94)90974-1 |
0.332 |
|
| Show low-probability matches. |